• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在维多利亚州通过输血传播丙型肝炎病毒、乙型肝炎病毒或艾滋病毒的风险。

The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.

作者信息

Whyte G S, Savoia H F

机构信息

Red Cross Blood Bank, Southbank, Victoria.

出版信息

Med J Aust. 1997 Jun 2;166(11):584-6. doi: 10.5694/j.1326-5377.1997.tb123269.x.

DOI:10.5694/j.1326-5377.1997.tb123269.x
PMID:9201178
Abstract

OBJECTIVE

To report the incidence rate of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV in Victorian repeat blood donors and to derive the residual risk of transmission of the viruses by screened blood transfusion.

DESIGN

The interval from the previous whole blood donation was extracted retrospectively from Victorian Red Cross Blood Bank records for each of the 358332 repeat donations given between March 1994 and December 1995. Records of repeat donors found positive for the viruses in this period were traced to the previous seronegative donation and accepted if screened by the same test. For each virus, the number of previous donations screened by the same test was calculated and the sum of all donation intervals used to derive the incidence of infection in the repeat donor population. Published intervals after infection (when a donation can be infective although seronegative) were used to calculate the risk of release of a seronegative unit which would be infective.

PARTICIPANTS AND SETTING

Homologous blood donors at the Red Cross Blood Bank of Victoria.

MAIN OUTCOME MEASURES

Incidence rate of HBV, HCV and HIV in regular blood donors and risk of infective donations being seronegative.

RESULTS

The incidence of infection in repeat donors was: HBV: 1.67 per 100000 person-years; HCV: 1.89 per 100000 person-years; and HIV: 1.31 per 100000 person-years. The risk of a seronegative repeat donation being infective was: HBV: 2.71 per million donations (adjusted to 6.45 to account for viraemias which remain seronegative); HCV: 4.27 per million donations; and HIV: 0.79 per million donations.

CONCLUSION

The risk of transmitting HCV, HBV or HIV by repeat blood donors is low and compares favourably with overseas data. Repeat donors have an incidence rate of HIV and HBV comparable to that of the general population, but the incidence rate of HCV is lower for repeat donors than in the general population.

摘要

目的

报告维多利亚州重复献血者中乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)的感染率,并推算经筛查的输血传播这些病毒的残余风险。

设计

从维多利亚红十字会血库记录中回顾性提取1994年3月至1995年12月期间358332次重复献血中每次献血距上次全血捐献的间隔时间。在此期间重复献血者中病毒检测呈阳性的记录追溯至上次血清学阴性的捐献,若经相同检测筛查则予以纳入。对于每种病毒,计算经相同检测筛查的既往捐献次数,并将所有捐献间隔时间总和用于推算重复献血者群体中的感染发生率。采用感染后公布的间隔时间(即捐献虽血清学阴性但仍具传染性的时间)来计算血清学阴性但具传染性的单位被放行的风险。

参与者与研究背景

维多利亚红十字会血库的同源献血者。

主要观察指标

定期献血者中HBV、HCV和HIV的感染率以及具传染性的捐献血清学阴性的风险。

结果

重复献血者的感染发生率为:HBV:每10万人年1.67例;HCV:每10万人年1.89例;HIV:每10万人年1.31例。血清学阴性的重复捐献具传染性的风险为:HBV:每百万次捐献2.71例(调整后为6.45例,以计入血清学阴性的病毒血症);HCV:每百万次捐献4.27例;HIV:每百万次捐献0.79例。

结论

重复献血者传播HCV、HBV或HIV的风险较低,与海外数据相比具有优势。重复献血者中HIV和HBV的感染发生率与普通人群相当,但重复献血者中HCV的感染发生率低于普通人群。

相似文献

1
The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.在维多利亚州通过输血传播丙型肝炎病毒、乙型肝炎病毒或艾滋病毒的风险。
Med J Aust. 1997 Jun 2;166(11):584-6. doi: 10.5694/j.1326-5377.1997.tb123269.x.
2
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.1990 - 2000年加拿大献血者中艾滋病毒、丙型肝炎、乙型肝炎和人类嗜T细胞病毒的发病率及残余风险估计率。
CMAJ. 2003 Oct 14;169(8):767-73.
3
Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.核酸检测未检出的窗口期献血导致乙肝病毒、丙肝病毒和艾滋病毒传播风险的数学模型
Transfusion. 2002 May;42(5):537-48. doi: 10.1046/j.1537-2995.2002.00099.x.
4
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.加拿大血液服务中心 HIV、HBV 和 HCV 的当前发病率和残余风险。
Vox Sang. 2012 Jul;103(1):83-6. doi: 10.1111/j.1423-0410.2012.01584.x. Epub 2012 Jan 31.
5
[Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].[1999年至2010年葡萄牙波尔图圣若昂中央医院(EPE)无偿献血中HIV、HCV和HBV残余风险的演变]
Acta Med Port. 2013 Jul-Aug;26(4):371-6. Epub 2013 Aug 30.
6
Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.1993 - 2001年英格兰乙肝病毒、丙肝病毒及人类免疫缺陷病毒感染性献血进入血液供应的风险评估
Vox Sang. 2003 May;84(4):274-86. doi: 10.1046/j.1423-0410.2003.00296.x.
7
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.德国红十字会献血服务机构核酸检测经验:超过3000万次人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒献血筛查结果
Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.
8
Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.阿联酋献血者中主要经输血传播的病毒感染的流行率、发病率和残余风险趋势:个体献血核酸检测的影响,2004 年至 2009 年。
Transfusion. 2012 Nov;52(11):2300-9. doi: 10.1111/j.1537-2995.2012.03740.x. Epub 2012 Jun 13.
9
Predonation screening of candidate donors and prevention of window period donations.候选献血者的预先筛查及窗口期献血的预防。
Transfusion. 2015 Feb;55(2):373-8. doi: 10.1111/trf.12809. Epub 2014 Aug 7.
10
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations.核酸检测用于全血献血中筛查艾滋病毒、丙型肝炎病毒和乙型肝炎病毒的成本效益
Transfusion. 2003 Jun;43(6):721-9. doi: 10.1046/j.1537-2995.2003.00392.x.

引用本文的文献

1
Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations.是否有必要对丙型肝炎进行双重检测?模拟澳大利亚献血中去除丙型肝炎抗体检测的风险。
Vox Sang. 2023 Jun;118(6):480-487. doi: 10.1111/vox.13430. Epub 2023 May 14.
2
Nucleic acid testing: Is it the only answer for safe Blood in India?核酸检测:它是印度安全用血的唯一答案吗?
Asian J Transfus Sci. 2016 Jan-Jun;10(1):79-83. doi: 10.4103/0973-6247.175423.
3
Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
富血小板血浆置换术用于减少围手术期异体输血
Cochrane Database Syst Rev. 2011 Mar 16(3):CD004172. doi: 10.1002/14651858.CD004172.pub2.
4
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.抗纤溶药物用于减少围手术期异体输血。
Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD001886. doi: 10.1002/14651858.CD001886.pub4.
5
Cell salvage for minimising perioperative allogeneic blood transfusion.细胞回收技术用于减少围手术期异体输血。
Cochrane Database Syst Rev. 2010 Apr 14;2010(4):CD001888. doi: 10.1002/14651858.CD001888.pub4.
6
The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。
J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.
7
Desmopressin for minimising perioperative allogeneic blood transfusion.去氨加压素用于减少围手术期异体输血。
Cochrane Database Syst Rev. 2004(1):CD001884. doi: 10.1002/14651858.CD001884.pub2.
8
Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.术前自体献血以减少围手术期异体输血。
Cochrane Database Syst Rev. 2002;2001(2):CD003602. doi: 10.1002/14651858.CD003602.